Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06565390 · ClinicalTrials.gov registry record · NA

Remote Oximeter Monitoring Post-discharge to Reduce Emergency Room Visits and Rehospitalization

A NA study of Emergencies, sponsored by University of Alabama at Birmingham.

Recruiting
Registry status
NA
Development phase
700
Enrollment target
1
Study location

NCT06565390: Recruiting NA study of Emergencies, sponsored by University of Alabama at Birmingham.

NCT06565390 is a NA study of Emergencies that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 700 participants, below the 9,222-participant average among 11 other Emergencies trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06565390, a NA study of Emergencies, is actively recruiting participants, sponsored by University of Alabama at Birmingham.

RECRUITING
Registry status
NA
Development phase
700 participants
Enrollment target
1
Study location

Study Summary

This randomized clinical trial will determine the efficacy of remote patient monitoring using an Owlet OSS 3.0 pulse oximeter for the reduction of emergency room visits and high-acuity rehospitalizations among high-risk infants after NICU discharge.

Primary Outcome

Number of emergency room visits and high-acuity rehospitalizations.

Conditions Studied

Interventions

  • DEVICE Babies in the Owlet monitor group

Study Locations (1)

Alabama

  • University of Alabama at Birmingham - Birmingham

Trial Details

FieldValue
Enrollment Target 700 participants
Start Date 2025-09-11
Est. Completion 2030-12-31
Phase NA
University of Alabama at Birmingham

1,160 total trials

What NCT06565390 shows while recruiting

NCT06565390 is an interventional study that assigns participants to a tested intervention. The registered 700 participants enrollment target is mid-sized for trials with a published cap, below the 9,222-participant average among 11 other Emergencies trials with a reported enrollment target (92% lower).

The record links to 1 condition, with Emergencies appearing as the primary indexed condition, and to 1 intervention - of which Babies in the Owlet monitor group is the first listed.

NCT06565390 reports a single indexed study location in Alabama.

Frequently Asked Questions

What is clinical trial NCT06565390 about?

NCT06565390 is a clinical study titled "Remote Oximeter Monitoring Post-discharge to Reduce Emergency Room Visits and Rehospitalization". This randomized clinical trial will determine the efficacy of remote patient monitoring using an Owlet OSS 3.0 pulse oximeter for the reduction of emergency room visits and high-acuity rehospitalizations among high-risk infants after NICU discharge.

What is the current status of trial NCT06565390?

This trial is currently recruiting. It is a NA study. The enrollment target is 700 participants. The study started on 2025-09-11. Estimated completion is 2030-12-31.

What conditions does trial NCT06565390 study?

This clinical trial studies the following conditions: Emergencies.

What interventions are being tested in trial NCT06565390?

The interventions under investigation include: Babies in the Owlet monitor group (DEVICE).

Who is sponsoring clinical trial NCT06565390?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06565390 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Emergencies

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06565390's enrollment target sits among peer trials

700 3rd of 11 higher than 9 of 11 other Emergencies trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Emergencies trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00900419 · 700 participants

    Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers

  • NCT01804686 · 700 participants · Phase 3

    A Long-term Extension Study of PCI-32765 (Ibrutinib)

  • NCT02107989 · 700 participants

    Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database

  • NCT02129543 · 700 participants

    Immune Reconstitution in Stem Cell Transplant Recipients

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06565390, the US trial registry maintained by the National Library of Medicine. NCT06565390 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.